Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Spinal Cord Injury Vaccines
Studies from University of Alabama, Department of Pathology have provided new information about spinal cord injury vaccines
June 25th, 2008
A new study, 'Revaccination of adults with spinal cord injury using the 23-valent pneumococcal polysaccharide vaccine,' is now available. According to a study from the United States, "Persons with spinal cord injury (SCI) are predisposed to develop pneumonia. This study was undertaken to determine the effect of revaccination with the pneumococcal vaccine on the immune response and the frequency of adverse reactions in this population." "An enzyme-linked immunosorbent assay was used to measure immunoglobulin G to selected pneumococcal capsular polysaccharides on sera collected from 23 persons who were revaccinated 5 years after primary vaccination. Sera were collected...
Source: Vaccine Weekly (2008-06-25)
|
